Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: Financial Reports 2019

Appendix 3B, Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 19, 2019

191121_Exercise of Options

Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 8, 2019

191108_Appendix 3B – Exercise of Options

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 1, 2019

191101_Appendix 4C and Quarterly Update

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By Richard MollardOctober 10, 2019

191010_Appendix 3B & s708 Notice

26 September, Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 26, 2019

190926_Exercise of Options

19 September: Appendix 4G & Corporate Governance Statement

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 23, 2019

190919_Appendix 4G & Corporate Governance Statement

19 September: Annual_Report

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 19, 2019

190919_Annual_Report

17 September: Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 17, 2019

190917_Appendix 3B Exercise of Options

Appendix 4E Preliminary Final Report

Financial Reports 2019, News & Announcements 2019By Richard MollardAugust 30, 2019

190830_Preliminary Final Report

Appendix 3B and s708 Notice

Financial Reports 2019, News & Announcements 2019By Richard MollardAugust 28, 2019

190828_Appendix 3B & s708 notice

123
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on TwitterPharmAust Retweeted
FightMNDF I G H T M N D@FightMND·
10h

Here's a perfect example of how we put your Big Freeze beanie purchases and donations to work in the fight against MND.

A new Australian clinical trial testing a cancer drug to treat MND is set to begin next month thanks to direct funding from FightMND.

https://fal.cn/3oVF4

Reply on Twitter 1529714129090527232Retweet on Twitter 15297141290905272322Like on Twitter 152971412909052723211Twitter 1529714129090527232
Load More...
Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top